Creative Biolabs launches integrated preclinical platform to accelerate biotherapeutics development and de-risk IND submission

In this article, find out more about the end-to-end preclinical development platform from Creative Biolabs. The integration streamlines the critical path from lead optimization through toxicology, directly addressing industry fragmentation and accelerating time-to-IND submission for complex biologics.